Literature DB >> 12153616

Expression of RB C pocket fragments in HSF induces delayed cell cycle progression and sensitizes to apoptosis upon cellular stresses.

Junah Chung1, Jae-We Cho, Won-Ki Baek, Seong-Il Suh, Taeg Kyu Kwon, Jong-Wook Park, Min-Ho Suh.   

Abstract

The retinoblastoma protein (RB) plays an important role in growth suppression through the formation of multiple protein complexes with its target proteins using A/B and C pockets. Even though the A/B and C pockets co-operate for growth suppression, the function of RB in growth arrest is inhibited by the coexpression of RB C fragments with full length RB in the absence of p53, which implies that C pocket fragments are likely to act as a dominant-negative inhibitor of RB function. In contrast, the loss of the RB functions in the presence of p53 triggers a cell cycle arrest or apoptosis by p53-dependent pathways. Thus, it still remains to be elucidated whether the expression of RB C pocket fragments in the presence of p53 induces delayed cell cycle progression and sensitizes cells to apoptosis through p53-dependent pathways. Our results show that the expression of RB C pocket fragments not only induces delayed cell cycle progression, which is mediated by the down-regulation of cyclin A, cyclin E, and E2F-1, but also sensitizes cells to apoptosis through p53-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153616      PMCID: PMC6496431          DOI: 10.1046/j.1365-2184.2002.00245.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  24 in total

1.  Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.

Authors:  L L Whitaker; H Su; R Baskaran; E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 2.  Replicative senescence: implications for in vivo aging and tumor suppression.

Authors:  J R Smith; O M Pereira-Smith
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

3.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase.

Authors:  L Magnaghi-Jaulin; R Groisman; I Naguibneva; P Robin; S Lorain; J P Le Villain; F Troalen; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

4.  Retinoblastoma protein recruits histone deacetylase to repress transcription.

Authors:  A Brehm; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

5.  Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels.

Authors:  J W Cho; W K Baek; S I Suh; S H Yang; J Chang; Y C Sung; M H Suh
Journal:  Liver       Date:  2001-04

6.  Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.

Authors:  P J Welch; J Y Wang
Journal:  Genes Dev       Date:  1995-01-01       Impact factor: 11.361

7.  Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses.

Authors:  L Szekely; W Q Jiang; F Bulic-Jakus; A Rosen; N Ringertz; G Klein; K G Wiman
Journal:  Cell Growth Differ       Date:  1992-03

8.  Mechanism of active transcriptional repression by the retinoblastoma protein.

Authors:  S J Weintraub; K N Chow; R X Luo; S H Zhang; S He; D C Dean
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

9.  p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.

Authors:  A Goga; X Liu; T M Hambuch; K Senechal; E Major; A J Berk; O N Witte; C L Sawyers
Journal:  Oncogene       Date:  1995-08-17       Impact factor: 9.867

10.  Interaction between the retinoblastoma protein and the oncoprotein MDM2.

Authors:  Z X Xiao; J Chen; A J Levine; N Modjtahedi; J Xing; W R Sellers; D M Livingston
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  2 in total

Review 1.  Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.

Authors:  Viktorija Juric; Brona Murphy
Journal:  Cancer Drug Resist       Date:  2020-03-19

2.  Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity.

Authors:  Zhenghu Chen; Zhenyu Wang; Jonathan C Pang; Yang Yu; Shayahati Bieerkehazhi; Jiaxiong Lu; Ting Hu; Yanling Zhao; Xin Xu; Hong Zhang; Joanna S Yi; Shangfeng Liu; Jianhua Yang
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.